NEW YORK--(BUSINESS WIRE)--CB Pharma Acquisition Corp. (“CB Pharma”) (NASDAQ:CNLM; CNLMU; CNLMR; CNLMW) announced today that it held its extraordinary general meeting of shareholders and that at such ...
Munich, Germany: The first drug to target a key enzyme that cancer cells need to keep them alive has shown that it is effective in controlling disease in patients with advanced kidney cancer when it ...
HOUSTON and THE WOODLANDS, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- McDermott International, Inc. ("McDermott") MDR and CB&I CBI today announced both companies have received the necessary stockholder ...
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results